Search Results - "Zimmermann, E M"

Refine Results
  1. 1

    Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis by Higgins, P D R, Schwartz, M, Mapili, J, Krokos, I, Leung, J, Zimmermann, E M

    Published in Gut (01-06-2005)
    “…Background and aims: Ulcerative colitis disease activity indices offer good statistical power but small changes in these indices may not be clinically…”
    Get full text
    Journal Article
  2. 2

    Intestinal Metabolism and Transport of 5-Aminosalicylate by ZHOU, S. Y, FLEISHER, D, PAO, L. H, LI, C, WINWARD, B, ZIMMERMANN, E. M

    Published in Drug metabolism and disposition (01-04-1999)
    “…The purpose of this study was to determine the characteristics of intestinal absorption and metabolism of 5-aminosalicylic acid (5ASA). Regional perfusions of…”
    Get full text
    Journal Article
  3. 3

    The quantitative validation of non‐endoscopic disease activity indices in ulcerative colitis by HIGGINS, P. D. R., LEUNG, J., SCHWARTZ, M., MAPILI, J., WREN, P. A., ZIMMERMANN, E. M.

    Published in Alimentary pharmacology & therapeutics (01-02-2007)
    “…Summary Background Ulcerative colitis disease activity indices have not been formally validated. Aim To analise quantitatively the psychometric and performance…”
    Get full text
    Journal Article
  4. 4

    Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease by Zimmermann, E M, Li, L, Hou, Y T, Mohapatra, N K, Pucilowska, J B

    “…Insulin-like growth factor (IGF)-I and its binding protein IGF binding protein 5 (IGFBP-5) were highly expressed in inflamed and fibrotic intestine in…”
    Get more information
    Journal Article
  5. 5

    Proliferative activity of well differentiated neuroendocrine tumours of the gut by Zimmermann, M E, Bosman, F T

    Published in Histology and histopathology (01-04-2003)
    “…Neuroendocrine tumours of the gastrointestinal tract are relatively uncommon neoplasms with, in spite of their characteristic morphology, relatively…”
    Get full text
    Journal Article
  6. 6

    Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone by Ulshen, M H, Dowling, R H, Fuller, C R, Zimmermann, E M, Lund, P K

    Published in Gastroenterology (New York, N.Y. 1943) (01-04-1993)
    “…Transgenic mice with a bovine growth hormone gene linked to a mouse metallothionein I promoter (growth hormone transgenics) are a model of chronic growth…”
    Get more information
    Journal Article
  7. 7

    Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats by McCall, R D, Haskill, S, Zimmermann, E M, Lund, P K, Thompson, R C, Sartor, R B

    Published in Gastroenterology (New York, N.Y. 1943) (01-04-1994)
    “…Subserosal injection of purified group A streptococcal peptidoglycan-polysaccharide (PG-APS) induces chronic relapsing granulomatous enterocolitis and systemic…”
    Get more information
    Journal Article
  8. 8

    Substance P as a mediator of colonic secretory reflexes by Cooke, H J, Sidhu, M, Fox, P, Wang, Y Z, Zimmermann, E M

    Published in The American journal of physiology (01-02-1997)
    “…The role of substance P in neural reflex pathways activated by stroking was investigated in muscle-stripped segments of distal colon from guinea pigs. Stroking…”
    Get full text
    Journal Article
  9. 9

    Nonviral Vector-Mediated Thymidine Kinase Gene Transfer and Ganciclovir Treatment in Leiomyoma Cells by Niu, Hairong, Simari, Robert D, Zimmermann, Ellen M, Christman, Gregory M

    Published in Obstetrics and gynecology (New York. 1953) (01-05-1998)
    “…Objective: To test the hypotheses that ganciclovir is cytotoxic to leiomyoma cells transfected with herpes simplex virus thymidine kinase and that estrogen…”
    Get full text
    Journal Article
  10. 10

    32 THE QUANTITATIVE VALIDATION OF NONINVASIVE DISEASE ACTIVITY INDICES IN ULCERATIVE COLITIS by Higgins, P. D.R., Krokos, I., Leung, J., Schwartz, M., Mapili, J., Zimmermann, E. M.

    Published in Journal of investigative medicine (01-03-2006)
    “…Background and AimsThere are no validated disease activity measures for ulcerative colitis. Current methods of validation are qualitative and provide no means…”
    Get full text
    Journal Article
  11. 11

    8 IS ENDOSCOPY NECESSARY FOR THE MEASUREMENT OF DISEASE ACTIVITY IN ULCERATIVE COLITIS? by Higgins, P. D.R., Schwartz, M., Mapili, J., Zimmermann, E. M.

    Published in Journal of investigative medicine (01-03-2005)
    “…ObjectivesMany disease activity indices are used to measure ulcerative colitis. Invasive indices incorporate an endoscopic score, while noninvasive indices do…”
    Get full text
    Journal Article
  12. 12

    Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver by Zimmermann, E M, Li, L, Hoyt, E C, Pucilowska, J B, Lichtman, S, Lund, P K

    “…The liver is a major source of circulating insulin-like growth factor I (IGF-I), and it also synthesizes several classes of IGF binding proteins (IGFBPs)…”
    Get more information
    Journal Article
  13. 13

    Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis by Zimmermann, E M, Sartor, R B, McCall, R D, Pardo, M, Bender, D, Lund, P K

    Published in Gastroenterology (New York, N.Y. 1943) (01-08-1993)
    “…Insulinlike growth factor I (IGF-I) is mitogenic for fibroblasts and smooth muscle cells and stimulates collagen synthesis. The present study tested the…”
    Get more information
    Journal Article
  14. 14

    Effect of substrate stability and canopy cover on stream invertebrate communities by Zimmermann, Erna M., Death, Russell G.

    “…Disturbance can be an important determinant of stream benthic invertebrate community structure. Whether this is a result of the direct loss of invertebrates,…”
    Get full text
    Journal Article
  15. 15

    Expression of insulin-like growth factor binding protein-4 and -5 mRNAs in adult rat forebrain by Stenvers, K L, Zimmermann, E M, Gallagher, M, Lund, P K

    Published in Journal of comparative neurology (1911) (01-01-1994)
    “…Accumulating evidence indicates that the insulin-like growth factors (IGFs) can act as neurotrophic factors. A family of at least six IGF binding proteins…”
    Get more information
    Journal Article
  16. 16

    Interference in ragweed pollen and honeybee venom radioallergosorbent tests by Zimmermann, E M, Yunginger, J W, Gleich, G J

    Published in Journal of allergy and clinical immunology (01-11-1980)
    “…We studied sera from patients sensitive to short ragweed (SRW) and honeybee venom (HBV) to investigate serum factors able to interfere with the measurement of…”
    Get more information
    Journal Article
  17. 17

    Measurement of IgG blocking antibodies by interference in the radioallergosorbent test by Gleich, GJ, Zimmermann, EM, Gleich, MC, Yunginger, JW

    Published in The Journal of immunology (1950) (01-02-1981)
    “…We previously found that sera of patients immunized with ragweed pollen extract contained a factor that interfered with the binding of IgE antibodies to…”
    Get full text
    Journal Article
  18. 18

    Preseasonal intranasal immunotherapy with nebulized short ragweed extract by Welsh, P W, Zimmermann, E M, Yunginger, J W, Kern, E B, Gleich, G J

    Published in Journal of allergy and clinical immunology (01-01-1981)
    “…We determined the effect of preseasonal intranasal short ragweed (SRW) immunotherapy in a double-blind, nonpaired, 20-wk study involving 33 SRW-sensitive…”
    Get more information
    Journal Article
  19. 19

    Immunotherapy with short ragweed fraction A:D-glutamic acid:D-lysine polymer in ragweed hay fever by Butterfield, J H, Gleich, G J, Yunginger, J W, Zimmermann, E M, Reed, C E

    Published in Journal of allergy and clinical immunology (01-01-1981)
    “…We report the first human trial of immunotherapy employing the nonimmunogenic carrier, D-glutamic acid:D-lysine linked to short ragweed (SRW) fraction A…”
    Get more information
    Journal Article
  20. 20

    Haemodynamic, metabolic and endocrine effects of short-term dexfenfluramine treatment in young, obese women by Andersson, B, Zimmermann, M E, Hedner, T, Björntorp, P

    Published in European journal of clinical pharmacology (01-03-1991)
    “…Seventeen normotensive, premenopausal women were treated with the 5-hydroxytryptamine-reuptake inhibitor dexfenfluramine 30 mg per day, for 4 days in a…”
    Get full text
    Journal Article